Skip to main content
U.S. flag

An official website of the United States government

Statin therapy for Alzheimer's disease: will it work?


Year of Publication:
Contact PI Name:
Suzana S. Petanceska
Contact PI Affiliation:
Nathan S. Kline Institute for Psychiatric Research, Dementia Research Group, Orangeburg, New York, USA
Steven DeRosa, Vicki Olm, Nichole Diaz, Ali Sharma, Tara Thomas-Bryant, Karen Duff, Miguel Pappolla, Lorenzo M. Refolo
Primary Reference (PubMED ID):
Funding Source:
Alzheimer's Association
Institute for the Study of Aging (ISOA)
Study Goal and Principal Findings:

This preclinical study aimed at testing the effects of Lipitor (atorvastatin) on beta amyloid peptide accumulation in the brains of PSAPP transgenic mice. Data showed that atorvastatin treatment lowered plasma cholesterol, had no effect on brain cholesterol, and attenuated beta amyloid peptide accumulation in brain. The data supported the notion that statin treatment may have value as a preventative therapy for Alzheimer's disease.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Small Molecule
Therapeutic Agent:
Therapeutic Target:
HMG-CoA Reductase

Animal Model

Model Information:
Model Type:
Strain/Genetic Background:
Not Reported

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest


Outcome Measured
Outcome Parameters
beta Amyloid Load
Brain-beta Amyloid Peptide 40
Brain-beta Amyloid Peptide 42
Plasma-Total Cholesterol